Marc-Arthur Loko
Affiliations: | Université de Bordeaux, Talence, Nouvelle-Aquitaine, France |
Google:
"Marc-Arthur Loko"Parents
Sign in to add mentor| François Dabis | grad student | 2009 | Université de Bordeaux | |
| (Epidémiologie clinique de la prise en charge des patients co-infectés par le VIH et le virus de l’hépatite C à partir des cohortes ANRS CO 03 Aquitaine et ANRS CO 13 HEPAVIH) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tan BK, Chalouni M, Ceron DS, et al. (2020) Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Carrieri MP, Serfaty L, Vilotitch A, et al. (2015) Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 40-8 |
| Miailhes P, Gilbert C, Lacombe K, et al. (2015) Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients. Liver International : Official Journal of the International Association For the Study of the Liver |
| Marcellin F, Roux P, Loko MA, et al. (2014) High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1190-2 |
| Marcellin F, Roux P, Winnock M, et al. (2014) Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert Review of Gastroenterology & Hepatology. 8: 351-8 |
| Bani-Sadr F, Loko MA, Pambrun E, et al. (2014) Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. Aids (London, England). 28: 1155-60 |
| Marcellin F, Lions C, Winnock M, et al. (2013) Self-reported alcohol abuse in HIV-HCV co-infected patients: A better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort) Addiction. 108: 1250-1258 |
| Loko MA, Bani-Sadr F, Valantin MA, et al. (2012) Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antiviral Therapy. 17: 1335-43 |
| Carrieri MP, Sogni P, Cohen J, et al. (2012) Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology (Baltimore, Md.). 56: 2010 |
| Salmon-Ceron D, Cohen J, Winnock M, et al. (2012) Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). Bmc Health Services Research. 12: 59 |